STAT

STAT+: A Novartis drug cut inflammation. Can it improve heart outcomes?

STAT+: A Novartis drug cut inflammation. Can it improve heart outcomes?WorldPing

A newly acquired Novartis drug cut signs of inflammation. The test will be whether that can improve people's heart health.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

Related news